This inventor holds 2 USPTO granted patents. Top assignees: Leland Stanford Junior University, Washington University. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,509 
1 out of 1,379 
Years Active: 2009-2013
Title: Keith M Rich: Innovator in Transglutaminase Inhibitors
Introduction
Keith M Rich is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biochemistry, particularly through his work on transglutaminase inhibitors. With a total of 2 patents, his innovations have the potential to impact various applications in medicine and biotechnology.
Latest Patents
Rich's latest patents focus on transglutaminase inhibitors and methods of use thereof. These patents provide innovative approaches to inhibiting transglutaminase, which is an enzyme involved in various biological processes. The methods outlined in his patents could lead to advancements in therapeutic applications.
Career Highlights
Throughout his career, Keith M Rich has worked with prestigious institutions such as Leland Stanford Junior University and Washington University. His experience in these research environments has allowed him to develop and refine his innovative ideas.
Collaborations
Rich has collaborated with esteemed colleagues, including Chaitan Khosla and Richard Edward Watts. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Keith M Rich is a prominent inventor whose work on transglutaminase inhibitors showcases his dedication to innovation in biochemistry. His contributions have the potential to lead to significant advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile